From strict moral standards to ethical neutrality: a policy-guided shift in the patentability of human embryonic stem cells in China

Attitudes towards human embryonic stem cells (hESCs) in China have witnessed a significant shift in 2020 that can be attributed to China’s policy guidance. For ethical reasons, stricter standards are adopted to curb related regulations and patent licensing. Through the introduction of policies, some...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Xuekai, Chen, Jiajv, Shu, Zhengyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687789/
https://www.ncbi.nlm.nih.gov/pubmed/33239089
http://dx.doi.org/10.1186/s13287-020-02013-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687789/
https://www.ncbi.nlm.nih.gov/pubmed/33239089
http://dx.doi.org/10.1186/s13287-020-02013-x

Ejemplares similares